Regimen | Dosing |
Rifamycin-based regimens¶ | |
IsoniazidΔ and rifapentine (administered with directly observed therapy weekly for 3 months; 3HP) |
|
Rifampin (self-administered daily for 4 months; 4R) |
|
Isoniazid monotherapy regimens | |
IsoniazidΔ |
|
LTBI: latent tuberculosis infection; TB: tuberculosis.
* The regimens summarized in the table are for treatment of LTBI due to Mycobacterium tuberculosis presumed to be susceptible to isoniazid and rifamycins. We do not favor use of isoniazid with rifampin for 3 months (3HR) for treatment of LTBI in patients with HIV infection; this regimen confers no benefit over isoniazid monotherapy in terms of efficacy or toxicity, but it does confer risk of drug interactions associated with rifampin.
¶ Rifamycin-containing regimens have the potential for clinically important drug-drug interactions, particularly with antiretroviral agents. Refer to the UpToDate topic on treatment of LTBI for further discussion.
Δ Peripheral neuropathy can occur among patients on LTBI regimens containing isoniazid due to interference with metabolism of pyridoxine and can be prevented with pyridoxine supplementation. For all patients with HIV infection on an LTBI regimen containing isoniazid, we coadminister pyridoxine (25 to 50 mg daily). We also administer pyridoxine to infants of breastfeeding mothers receiving INH.
◊ The duration of isoniazid therapy depends on TB incidence rate. For settings with TB incidence <500 per 100,000 population, we favor a 9-month duration given its established efficacy. A 6-month duration provides some protection; in the setting of difficulty with adherence, providers may prefer to concentrate efforts in ensuring 6 months of therapy. This approach is favored by the World Health Organization (WHO). However, regimens shorter than 9 months should not be used for patients with fibrotic lesions on chest radiograph. For settings with TB incidence ≥500 per 100,000 population, we are in agreement with the WHO guidelines which recommend a duration of at least 36 months. Refer to UpToDate topic on treatment of LTBI for further discussion.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟